Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Aphex BioCleanse Systems Inc. Stock Analysis SNST
Sunset Capital Assets, Inc. is a holding company, which engages in the production of hydrogen-based disinfectant and pesticide products known as Hy-IQ Water. The company is headquartered in Pittsford, New York. The firm is the developer and manufacturer of the non-alcoholic, non-toxic, hydrogen-based disinfecting technology. The firm produces hydrogen-based disinfectant and pesticide products. Its product, Hy-IQ Water, uses a process that attaches water molecules to hydrogen ions to breach the cell walls of single-celled exoskeleton organisms to more complex exoskeletons such as flying or crawling insects (bugs). The Company’s products are distributed both in the United States and internationally for various sanitizing applications. Its products include SanAphex, DermAphex, Medaphex, VegAphex, AgrAphex, VetAphex and DentAphex. DermAphex is used to kill germs without the effects of alcohol, leaving skin smooth and fresh. SanAphex is a surface disinfectant that will not bleach or discolor surfaces. MedAphex is a sting-free wound wash. VetAphex is used for the protection and treatment of animals and livestock.
Read More Aphex BioCleanse Systems Inc (SNST) Chart
Key Statistics of Aphex BioCleanse Systems Inc (SNST)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
22.66KP/E Ratio (TTM)
-52 Week Range
Market Cap
265.92KAvg. Volume
9536.50Dividend Yield
-Financial Metrics & Statements of Aphex BioCleanse Systems Inc (SNST)
FAQ's for Aphex BioCleanse Systems Inc (SNST)
- According to Musaffa’s Shariah screening methodology, Aphex BioCleanse Systems Inc (SNST) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aphex BioCleanse Systems Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aphex BioCleanse Systems Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aphex BioCleanse Systems Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aphex BioCleanse Systems Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aphex BioCleanse Systems Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.